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THE GROWING HAIR ROOTS OF THE HUMAN SCALP AND
MORPHOLOGIC CHANGES THEREIN FOLLOWING
AMETHOPTERIN THERAPY*
EUGENE J. VAN SCOTT, M.D., RICHARD P. REINERTSON, M.D. AND ROBERT STEINIIULLER
The hair roots of man, as in most animals, cyclically pass through periods when
hair is actively produced (anagen) and periods of total mitotic quiescence
(telogen). In many animals all the hairs of the pelage synchronously pass from
one phase of the cycle to the other. In man, however, the growth pattern is a
mosaic one wherein the state of activity of any one hair root is completely inde-
pendent of that of neighboring hairs (1, 2, 3). Hence all stages of the growth cycle
are simultaneously found in the pelage of man.
The growing hair root of the human scalp, producing approximately 0.35 mm.
of hair shaft daily (4, 5), is a tissue of high metabolic and mitotic activity. Hair
loss as a sequela to toxicity induced by drugs or disease is evidence that the hair
root is sensitive to metabolic or mitotic interferences.
Folic acid antagonists used chemotherapeutically, such as aminopterin and
amethopterin, have certain undesirable side effects. Among the most serious of
these phenomena is depression of hematopoiesis, reflected by a decrease of
cellular elements of the circulating blood. A less serious phenomenon is inter-
ference with the growth of hair on the scalp, the result of which is marked loss of
hair. The mechanism of this hair loss is unknown.
The present report describes a technic for examining hair roots. Microscopic
changes in the hair root following amethopterin (methotrexate) therapy are
described.
THR METHOD AND MATERIAL
Human hair was pulled from the parieto-occipital scalp by means of a surgical needle-
holding forceps, the jaws of which had been covered on the grasping surfaces with one to
several layers of cellulose tape to insure a tight closure and prevent slipping of hair shafts
during the pulling procedure. Approximately fifty hairs were simultaneously grasped close
to the surface of the scalp and extracted with a quick, forceful pull. The proximal ends of
the extracted hairs were cut off and dropped into a 5.5 cm. x 1.5 cm. glass petri dish, the
bottom of which was covered with water. A grid pattern of 16 divisions had previously been
scored on the underside of the petri dish. The root ends of at least 100 hairs were thus ob-
tained. Aggregates of hairs in the water were dispersed by means of a dissecting needle.
In order to minimize movement of the hair roots on the grid, two 24 mm. X 40 mm. cover
glasses were floated on the surface at right angles to each other and the excess water re-
moved with an eye dropper.
The hair roots were examined with a dissecting microscope under 20X and 45X magnifi-
cation, using transmitted light subdued by covering the sub-stage mirror with a sheet of
lens tissue.
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Hair roots were obtained from staff physicians, laboratory personnel, and patients hos-
pitalized for neoplastic diseases. Data obtained from microscopic examination of the hair
roots included the number of roots present, the number in anagen phase of the growth cycle,
the number in telogen phase, and the number in catagen (involutional phase between
anagen and telogen). The hair roots of patients receiving amethopterin therapeutically were
examined before administration of the drug and at intervals thereafter to detect morpho-
logic changes which might occur.
RESULTS
Differential counting of types o1 hair roots. Roots of hairs pulled from the
human scalp may be identified as either anagen (growing) or telogen (resting)
when viewed microscopically with transmitted light. An actively growing
(anagen) root was characterized by a darkly appearing keratogenous zone, im-
mediately distal to the hair bulb; melanin pigment usually was seen within the
matrix of the bulb; the internal root sheath and external root sheath were either
present and intact, partially present, or absent (Figures 1, 2, 3, 4). A resting
(telogen) root had no keratogenous zone, and it usually had no melanin pigment.
Although the resting root had no internal or external root sheath, its club-shaped
keratinized tip was surrounded by an epithelial sac (Figures 7, 8). Hair roots in
transition from anagen to telogen (catagen) could be identified by the fact that
they possessed both internal and an external root sheaths, as well as a keratiniz-
ing bulb (Figures 5, 6).
These criteria permitted differential counting of the three types of hair roots
described, and the number of anagen hairs was expressed as a percentage of the
total number of roots present. The remaining hair roots comprised preponderantly
telogen hairs, since catagen hairs were rather uncommonly seen.
Reliability of the method. To determine the limits of accuracy of a single differ-
ential counting of hair roots repeated examinations were performed on nine pa-
tients hospitalized for neoplastic diseases at a time when they were receiving no
chemotherapy for their disease and no other therapy which is known or suspected
to affect hair growth. In each patient one hundred or more scalp hair roots were
extracted and examined at intervals of one week or less. In each patient the per-
centage of growing hairs found on the first examination and that found on the
second examination made up a pair for comparison; similarly the percentage
found on the second examination and that of the third examination comprised
another pair; the third in turn was compared with the fourth, etc. The per-
centages of each pair were averaged and the error of either percentage expressed
as the percentage points which either deviated from this average (mean). In
twenty-five such paired determinations the deviation from the mean ranged from
o to 4.5 percentage points; the average deviation and median deviation were
1.5 and 1.0 percentage points respectively.
Range of proportion of growing hairs in scalps of normals. Examination of the
roots of scalp hairs from sixteen healthy staff physicians and laboratory workers
who had no discernible diseases of the scalp was performed. This group consisted
of 11 males and 5 females; fifteen were white, one was Negro; their ages ranged
from 18 to 38 years. The proportion of growing hairs ranged from 63 %—96 %
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Fin. 1 (sketch) and Fin. 2 (photograph). Normal anagen (growing) root of scalp hair.
X17.
Fin. 3 (sketch) and Fin. 4 (photograph). Normal anagen root of scalp hair without bulbar
portions of external and internal sheaths. X41.
(Table 1). No correlation of age or sex to proportion of growing hairs could be
made in this group.
Range of proportion of growing hairs in scalps of patients with neo plastic diseases.
The roots of scalp hairs from twenty-four white patients with neoplastic diseases
were examined. The ages of these patients ranged from 4 years to 89 years. Nine
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were female, fifteen were male. Ten had a diagnosis of acute leukemia, 3 had a
diagnosis of melanoma; there were 2 cases each of Hodgkin's disease, carcinoma
of breast, and carcinoma of the stomach; there was one case each of carcinoma of
the prostate, lung, and skin, and one case each of chronic leukemia and chorio-
FIG. 5 (sketch) and FIG. 6 (photograph). Normal catagen (involuting) root of scalp hair.
X45.
FIG. 7 (sketch) and FIG. 8 (photograph). Normal telogen (resting) root of scalp hair. X43.
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carcinoma. The proportion of growing hairs found ranged from 24% to 98 %;
the median and mean were 92 % and 77 % respectively. In this group of patients
no correlation of proportion of growing hairs with sex or diagnosis could be made.
The range of the proportions of growing hairs was, however, greater than that
found in normals.
Changes in proportion of growing hairs over periods of time in patients with neo-
plastic diseases. Repeated examinations of the roots of scalp hairs were done on
eleven patients with neoplastic diseases during periods when these patients re-
ceived no therapy which is known or suspected to affect hair growth. The pa-
tients were followed from 3 to 14 weeks; examinations of their hair roots were
generally done once weekly. Comparison of the proportion of growing hairs
found on the last examination with that of the first examination revealed that in
one case the proportion of hairs remained unchanged; in four cases the proportion
increased, the largest increase being 9 %; in six cases the proportion diminished,
the greatest decrease being 9 % (Table 2).
Changes in the hair root following amethopterin therapy. All changes due to
amethopterin were confined to anagen hairs and were the result of reversible
atrophy of the hair bulb. These effects were observed in 10 patients who were
given amethopterin intravenously in single doses varying from 2.0 mgm./kg.
TABLE I
Proportion of growing (Anagen) hairs in the scalp of normal individuals
Ages Females Males
% Growing hairs
Range Median Mean
18—26
28—38
2
3
5
6
82—96
63—91
86
86
87
82
Total 18—38 5 11 63—96 86 84
TABLE 2
Changes in proportion of growing (Anagen) hairs in the scalp of patients with neoplastic
disease
Patient of Examinations Interval (days)
% of growing hairs
Initial Final Change
1
2
3
4
5
6
7
8
9
10
11
4
7
9
4
2
2
5
7
9
13
4
36 92
28 77
26 87
24 93
28 43
26 24
33 84
44 94
98 96
103 81
20 85
90
68
84
99
52
32
93
89
96
77
77
—2
—9
—3
+6
+9
+8
+9
—5
0
—4
—8
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FIG. 9. Atrophy of bulb of scalp hair five days following amethopterin therapy. X27.
FIG. 10. Constriction in shaft of scalp hair immediately above keratogenous zone eight
days following amethopterin therapy. X70.
FIG. 11. Constriction in distal portion of shaft of scalp hair fourteen days following
amethopterin therapy. X27.
FIG. 12. Hair broken at site of severe constriction in shaft induced by amethopterin.
X80.
body weight to 15.0 mgm./kg. body weight, and in five patients who were given
the drug orally or intravenously in repeated daily doses which varied from 2.5
mgm./day to 30 mgm./day. The ages of the patients ranged from 2 years to 67
years.
Examinations of hair roots were performed before and after the institution of
amethopterin therapy. Since changes were not expected to occur prior to one
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week after therapy was begun, post-treatment examinations were not performed
prior to this time in most cases. Changes were detected however in anagen hair
roots of one patient five days following intravenous administration of the drug
in a single dose of 4 mgm./kg. body weight. Changes were confined to the matrix
portion of the bulb, the diameter of which was diminished (Figure 9).
Constriction of the hair shaft immediately distal to the keratogenous zone
(Figure 10) was observed in three patients on the eighth, ninth, and tenth days
after intravenous administration of amethopteriri in single doses of 5 mgm., 8
mgm., and 15 mgm./kg. body weight respectively.
un all patients who received amethopterin intravenously in single doses,
marked constrictions in the shafts of scalp hairs were seen two weeks following
the administration of the drug (Figure 11). Many hairs were broken off by the
extraction procedure at a point of severe constriction and had a characteristic
appearance (Figure 12). Similar constrictions were observed to occur in the hairs
of patients who were given amethopterin orally or intravenously in repeated
daily doses and appeared two weeks or more after administration of the first
dose.
Hairs which were broken off at the site of constriction were arbitrarily used as
a criterion for severe effect of the drug on hair growth. The number of such hairs
was established for each patient by differential examination of one hundred or
more extracted hairs; the number of anagen hairs which did not break off at a
constricted site was similarly established. The remaining hairs were telogen
hairs and were morphologically normal. Such differential examinations were
done repeatedly on five patients during periods of two weeks or more. The greatest
proportion of broken hairs was found in a patient who received a large single
intravenous dose of amethopterin (10 mgm./kg/body weight); on the 16th day
after administration of the drug all hairs, excepting those with telogen roots,
were found to be broken off at a site of severe constriction.
DiSCUSSiON
The morphologic changes in the roots and shafts of scalp hairs described above
appeared in the absence of, or prior to, clinically evident spontaneous loss of
hair. The changes varied in severity, the most marked occurring in a patient re-
ceiving one of the higher doses of amethopterin. Although the effect of amethop-
term on reproduction of the cells of the hair bulb was severe the bulb rapidly
recovered to continue producing a morphologically normal hair. Progressive
atrophy of the hair bulb, as may be seen following ionizing radiation (6), did not
occur. Hair loss resulting from amethopterin therefore occurs by breaking off
of the hair at a site of constriction in the hair shaft, and not by falling out at the
roots.
The presence and magnitude of these changes associated with amethapterin
therapy might be utilized to differentiate between toxicity due to disease and
toxicity due to drug, particularly in patients with leukemia where difficulties
in making this differentiation are frequently encountered.
Growth-inhibiting effects of metabolic antagonists other than amethopterin
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may also be detectable by morphologic changes induced in the hair root and may
serve to further evaluate the anti-mitotic action of such compounds in man.
SUMMARY
1. Roots of manually extracted scalp hairs were examined microscopically and
the proportions of growing (anagen) hairs to resting (telogen) hairs determined.
2. Most of the hairs in the scalps of normal adults were found to be in the
growing stage.
3. The range in the proportions of growing hairs was found to be greater in
patients with neoplastic diseases than in healthy individuals.
4. Anagen hair bulbs were found to become atrophic in response to amethop-
term therapy and temporarily produced a hair shaft markedly diminished in
diameter. The bulb recovered promptly following cessation of therapy, and again
produced a hair shaft of normal diameter. This resulted in a focal constriction
of the hair shaft.
5. Loss of hair following amethopterin is due to breaking of hair shafts at a
constricted site, and is not due to hairs falling out at the roots.
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